NCT00651560View on ClinicalTrials.gov

Vytorin As Strategy To Reduce Dislipidemia In Adults (0653A-148)

PHASE3CompletedINTERVENTIONAL
Enrollment

167

Participants

Timeline

Start Date

November 1, 2005

Primary Completion Date

December 23, 2005

Study Completion Date

December 23, 2005

Conditions
Hyperlipidemia
Interventions
DRUG

ezetimibe (+) simvastatin

ezetimibe 10mg (+) simvastatin 20 mg once daily for 4 weeks of treatment.

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT00651560 - Vytorin As Strategy To Reduce Dislipidemia In Adults (0653A-148) | Biotech Hunter | Biotech Hunter